Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma

NCT02993276 is registered in ClinicalTrials.gov with Polyganics BV as lead sponsor.

NCT NCT02993276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02993276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Lead sponsor
Polyganics BV
Phase
Observational
Overall status
Completed
Start date
April 17, 2017
Completion date
August 30, 2020
Enrollment
73 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

neuroma